Multicenter randomized comparison of direct vs. conventional stenting: The DIRECTO trial

Catheterization and Cardiovascular Interventions

Volumn 58, Issue 4, 2003, Pages 434-440

  Ballarino, Miguel A ^a   Moreyra Jr , Eduardo ^a   Damonte, Aníbal ^b   Sampaolesi, Alberto ^c   Woodfield, Scott ^d   Pacheco, Guillermo ^c   Caballero, Gustavo ^c   Picabea, Eduardo ^b   Baccaro, Jorge ^e   Tapia, Luis ^f   Lascano, Esteban Ruiz ^a  

^a HOSPITAL PRIVADO   (Argentina)

^b Sanatorio Parque e Instituto Cardiovascular de Rosario   (Argentina)

^c Instituto Modelo de Cardiología Privado de Córdoba   (Argentina)

^d CareAlliance Health Services   (United States)

^e Instituto de Cardiología Juana F Cabral   (Argentina)

^f Hemodinamia Salta   (Argentina)

Author keywords

Angioplasty; Stents

Indexed keywords

CREATINE KINASE;

ADULT; AGED; ARTERY DISSECTION; ARTICLE; BALLOON CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY STENT; ENZYME ASSAY; FEMALE; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; SAFETY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BALLOON DILATATION; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STENTS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 12244284586     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10404     Document Type: Article

References (25)

1. Belli G, Ellis SG, Topol EJ. Stenting for ischemic heart disease. Prog Cardiovasc Dis 1997;40:159-182.
2. Brophy JM. Public policy and coronary stenting: a different perspective. Can J Cardiol 1998;14:54-57.
3. Dorros G, Cowley MJ, Simpson J, Bentivoglio LG, Block PC, Bourassa M, Detre K, Gosselin AJ, Gruntzig AR, Kelsey SF, Kent KM, Mock MB, Mullin SM, Myler RK, Passamani ER, Stertzer SH, Williams DO. Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA registry. Circulation 1983;67:723-730.
4. Guiteras Val P, Bourassa MG, David PR, Bonan R, Crepeau J, Dyrda I, Lesperance J. Restenosis after successful percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience. Am J Cardiol 1987;60:50B-55B.
5. Pentousis D, Guerin Y, Funck F, Zheng H, Toussaint M, Corcos T, Favereau X. Direct stent implantation without predilatation using the MultiLink stent. Am J Cardiol 1998;82:1437-1440.
6. Hoffmann M, Werner GS, Ferrari M, Richartz BM, Figulla HR. Direct coronary stent implantation without predilatation: a new therapeutic approach with a special balloon catheter design. Z Kardiol 1999;88:123-132.
7. Briguori C, Sheiban I, De Gregorio J, Anzuini A, Montorfano M, Pagnotta P, Marsico F, Leonardo F, Di Mario C, Colombo A. Direct coronary stenting without predilation. J Am Coll Cardiol 1999;34:1910-1915.
8. Hamon M, Richardeau Y, Lecluse E, Saloux E, Sabatier R, Agostini D, Filmont JE, Grollier G, Potier JC. Direct coronary stenting without balloon predilation in acute coronary syndromes. Am Heart J 1999;138(1 Pt 1):55-59.
9. Wilson SH, Berger PB, Mathew V, Bell MR, Garratt KN, Rihal CS, Bresnahan JF, Grill DE, Melby S, Holmes DR Jr. Immediate and late outcomes after direct stent implantation without balloon predilation. J Am Coll Cardiol 2000;35:937-943.
10. Chan AW, Carere RG, Solankhi N, Dodek A, Webb JG. Coronary stenting without predilatation in a broad spectrum of clinical and angiographic situations. J Invas Cardiol 2000;12:75-79.
11. Ormiston JA, Webster MW, Ruygrok PN, Elliott JM, Simmonds MB, Meredith IT, Devlin GP, Stewart JT, Dixon SR, Price S, Ellis CJ, West TM. A randomized study of direct coronary stent delivery compared with stenting after predilatation: the NIR future trial: on behalf of the NIR Future Trial investigators. Cathet Cardiovasc Intervent 2000;50:377-381.
12. Carrie D, Khalife K, Citron B, Izaaz K, Hamon M, Juiliard JM, Leclercq F, Fourcade J, Lipiecki J, Sabatier R, Boulet V, Rinaldi JP, Mourali S, Fatouch M, El Mokhtar E, Aboujaoude G, Elbaz M, Grolleau R, Steg PG, Puel J. Comparison of direct coronary stenting with and without balloon predilatation in patients with stable angina pectoris: BET study group. Am J Cardiol 2001;87:693-698.
13. Laarman G, Muthusamy TS, Swart H, Westendorp I, Kiemeneij F, Slagboom T, van der Wieken R. Direct coronary stent implantation: safety, feasibility, and predictors of success of the strategy of direct coronary stent implantation. Cathet Cardiovasc Intervent 2001;52:443-448.
14. Le Breton H, Boschat J, Commeau P, et al. Randomized comparison of coronary stenting with and without balloon predilatation in selected patients. Heart 2001;86:302-308.
15. Foley DP, Pieper M, Wijns W, Suryapranata H, Grollier G, Legrand V, de Scheerder I, Hanet C, Puel J, Mudra H, Bonnier HJ, Colombo A, Thomas M, Probst P, Morice M, Kleijne J, Serruys PW, on behalf of the MAGIC 5L investigators. The influence of stent length on clinical and angiographic outcome in patients undergoing elective stenting for native coronary artery lesions; final results of the MAGIC 5L study. Eur Heart J 2001;22:1585-1593.
16. Goldberg SL, Loussararian A, De Gregorio J, Di Mario C, Albiero R, Colombo A. Predictors of diffuse and aggressive intra-stent restenosis. J Am Coll Cardiol 2001;37:1019-1025.
17. Maiello L, Colombo A, Gianrossi R, McCanny R, Finci L. Coronary stenfing for treatment of acute or threatened closure following dissection after coronary balloon angioplasty. Am Heart J 1993;25:1570-1575.
18. George BS, Voorhees WD III, Roubin GS, Fearnot NE, Pinkerton CA, Raizner AE, King SB, Holmes DR, Topol EJ, Kereiakes DJ, et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. J Am Coll Cardiol 1993;22:135-143.
19. Robinson NM, Thomas MR, Jewitt DE, Wainwright RJ. Comparison of clinical, outcome after elective and "bail out" coronary stent insertion. J Invas Cardiol 1995;7:156-164.
20. Harrington RA. Cardiac enzyme elevations after percutaneous coronary intervention: myonecrosis, the coronary microcirculation and mortality. J Am Coll Cardiol 2000;35:1142-1144.
21. Saucedo JF, Mehran R, Dangas G, Hong MK, Lansky A, Kent KM, Satler LF, Pichard AD, Stone GW, Leon MB. Long-term clinical events following creatine kinase: myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol 2000;35:1134-1141.
22. Kini A, Marmur JD, Kini S, Dangas G, Cocke TP, Wallenstein S, Brown E, Ambrose JA, Sharma SK. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention. J Am Coll Cardiol 1999;34:663-671.
23. Tardiff BE, Califf RM, Tcheng JE, Lincoff AM, Sigmon KN, Harrington RA, Mahaffey KW, Ohman EM, Teirstein PS, Blankenship JC, Kitt MM, Topol EJ. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention: IMPACT-II investigators. J Am Coll Cardiol 1999;33:88-96.
24. Alexander JH, Sparapani RA, Mahaffey KW, Deckers JW, Newby LK, Ohman EM, Corbalan R, Chierchia SL, Boland JB, Simoons ML, Califf RM, Topol EJ, Harrington RA. Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation: PURSUIT steering committee. JAMA 2000;283:347-353.
25. Ooi DS, Isotalo PA, Veinot JP. Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology. Clin Chem 2000;46:338-344.